1. Home
  2. CAN vs PRTA Comparison

CAN vs PRTA Comparison

Compare CAN & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • PRTA
  • Stock Information
  • Founded
  • CAN 2013
  • PRTA 2012
  • Country
  • CAN Singapore
  • PRTA Ireland
  • Employees
  • CAN N/A
  • PRTA N/A
  • Industry
  • CAN Semiconductors
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • PRTA Health Care
  • Exchange
  • CAN Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • CAN 330.5M
  • PRTA 472.1M
  • IPO Year
  • CAN 2019
  • PRTA N/A
  • Fundamental
  • Price
  • CAN $0.74
  • PRTA $8.20
  • Analyst Decision
  • CAN Strong Buy
  • PRTA Buy
  • Analyst Count
  • CAN 6
  • PRTA 10
  • Target Price
  • CAN $2.50
  • PRTA $14.86
  • AVG Volume (30 Days)
  • CAN 32.6M
  • PRTA 1.2M
  • Earning Date
  • CAN 08-14-2025
  • PRTA 08-04-2025
  • Dividend Yield
  • CAN N/A
  • PRTA N/A
  • EPS Growth
  • CAN N/A
  • PRTA N/A
  • EPS
  • CAN N/A
  • PRTA N/A
  • Revenue
  • CAN $345,360,000.00
  • PRTA $10,341,000.00
  • Revenue This Year
  • CAN $90.25
  • PRTA N/A
  • Revenue Next Year
  • CAN $42.94
  • PRTA $389.77
  • P/E Ratio
  • CAN N/A
  • PRTA N/A
  • Revenue Growth
  • CAN 82.40
  • PRTA N/A
  • 52 Week Low
  • CAN $0.53
  • PRTA $4.32
  • 52 Week High
  • CAN $3.27
  • PRTA $22.83
  • Technical
  • Relative Strength Index (RSI)
  • CAN 51.63
  • PRTA 58.73
  • Support Level
  • CAN $0.64
  • PRTA $8.05
  • Resistance Level
  • CAN $0.80
  • PRTA $8.73
  • Average True Range (ATR)
  • CAN 0.05
  • PRTA 0.38
  • MACD
  • CAN 0.00
  • PRTA -0.05
  • Stochastic Oscillator
  • CAN 59.38
  • PRTA 47.62

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

Share on Social Networks: